Events
Previous
Welcome to a guest lecture with Dr. Ton N. Schumacher fromThe Netherlands Cancer Institute and Oncode Institute. The lecture is supported by Norsk Hydros Fond.
Hosted by PRIMA and the Cancer Grand Challenges MATCHMAKER team.
Welcome to an exciting seminar with Ronald N. Germain, NIH/NIAID, US, and Sine R. Hadrup, Technical University of Denmark.
Welcome to a seminar with Prof. Stefan Zielonka, Technical University of Darmstadt, and Executive Director at Merck Healthcare KGaA (EMD Serono), Germany, and Assistant Professor Sai Sundar Rajan Raghavan from University of Copenhagen.
Welcome to a seminar on cancer immunology with Prof Satu Mustjoki and Prof Bjørn Tore Gjertsen
Welcome to a seminar with Prof. Inge Marie Svane from University of Copenhagen, and Prof. Trude Helen Flo from the Norwegian University of Science and Technology (NTNU)
Welcome to a seminar with Dr. Emily Mace from Columbia University Irving Medical Center, and Fredrik Bergh Thorén from Sahlgrenska Cancer Center and the University of Gothenburg.
Welcome to guest lectures by Rino Rappuoli and Emanuele Andreano. Prof Rappaouli is one of the world leading experts on vaccines and the Scientific Director of the Biotecnopolo di Siena Foundation, Italy.
Welcome to guest lecture by Prof Victor Appay, Research Director, University of Bordeaux, France
Norwegian Society for Immunology (NSI) together with Precision Immunotherapy Alliance (PRIMA) welcome you to a seminar on vaccination and humoral immunity, Monday October 27 from 13.00.
PRIMA is pleased to host a distinguished symposium featuring leading researchers from Stanford University, the Wellcome Sanger Institute, and Karolinska Institutet. We invite you to join us for an engaging program highlighting recent advances in immunotherapy, gene regulation, and epigenetic research.
Welcome to an exciting workshop with Dr Aaron Newman from Stanford, Visiting Professor at PRIMA. Newman is one the world leading experts on computational methods to study immuno-oncology and the spatial microenvironment.
Welcome to guest lecture by Prof Evan W. Newell, Professor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center.
Welcome to seminar cohosted by the K.G. Jebsen Centre for B cell malignancies and PRIMA with Dr. Helene Hallböök and Dr. Ingo Ringshausen
Welcome to an exciting seminar hosted by PRIMA Feb 5 with Dr. Marcus Buggert and Dr. Mustafa Diken
Professor Michael Dustin will give a talk on October 30th.
Welcome to an exciting chalk talk/lecture with PRIMA Visiting Prof. Mark Cragg “Precision medicine and targeting in the era of immunotherapy”.
Welcome to seminar arranged by PRIMA with Visiting Prof. Mark Cragg from the University of Southampton and local speakers
Welcome to a PRIMA guest lecture by Professor Gillian Griffiths, University of Cambridge, United Kingdom
Welcome to PRIMA seminar arranged by Prof. Jan Terje Andersen in collaboration with UiO Growth House and Norwegian Society of Immunology
Welcome to a guest lecture by Dr. Stephen Beers, Professor of Immunology & Immunotherapy, University of Southampton, UK
Dr. Stephen Beers will give a talk on April 24th.
Welcome to a distinguished guest lecture by Prof. Ronald Germain, NIH. Prof. Germain is part of the Scientific Advisory Board of PRIMA, and will share his exciting work on deciphering immune responses with in situ imaging. The event is hosted by PRIMA and the Norwegian Society of Immunology (NSI)
Welcome to a seminar with Magnus Essand and Anna Dimberg from Uppsala University on CAR-T cell clinical trials for B cell lymphoma and glioblastoma, and the role of vascularization and tumor micro environment for efficient anti-tumor T cell responses in glioblastoma
PRIMA is hosting a visit from BioInvent, a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates. CSO Björn Frendéus will give a talk focusing on how antibodies are used as treatments and the importance of cutting edge science in collaboration between academia and industry to generate new and safe therapeutics.